Structures by: Varughese S.
Total: 122
C23H21ClO7
C23H21ClO7
Chemical Science (2020)
a=9.040(9)Å b=16.150(8)Å c=14.320(6)Å
α=90° β=101.670(6)° γ=90°
C27H24O3
C27H24O3
Organic letters (2014) 16, 24 6374-6377
a=16.330(13)Å b=15.140(13)Å c=17.416(15)Å
α=90° β=90° γ=90°
Aspirin form II
C9H8O4
Chemical Science (2011) 2, 11 2236
a=12.1016(4)Å b=6.4721(2)Å c=11.3344(4)Å
α=90.00° β=111.593(1)° γ=90.00°
Aspirin form II
C9H8O4
Chemical Science (2011) 2, 11 2236
a=12.3578(7)Å b=6.5315(8)Å c=11.4964(7)Å
α=90.00° β=112.436(3)° γ=90.00°
C10.5H10.5N10.5O10.5
C10.5H10.5N10.5O10.5
Organic & biomolecular chemistry (2020) 18, 8 1588-1593
a=9.842(4)Å b=9.949(4)Å c=11.468(5)Å
α=100.231(6)° β=105.032(6)° γ=95.125(4)°
C21H23NO
C21H23NO
Organic & biomolecular chemistry (2020) 18, 8 1588-1593
a=20.236(12)Å b=5.793(3)Å c=14.906(8)Å
α=90° β=90° γ=90°
C22H20BrNO4
C22H20BrNO4
Organic & biomolecular chemistry (2015) 13, 12 3589-3592
a=5.414(6)Å b=20.283(19)Å c=18.171(17)Å
α=90.00° β=92.881(19)° γ=90.00°
C23H16BClF4O
C23H16BClF4O
Chemical communications (Cambridge, England) (2018) 54, 88 12463-12466
a=13.337(6)Å b=10.087(4)Å c=15.170(7)Å
α=90° β=93.785(7)° γ=90°
C23H29BrN5O6
C23H29BrN5O6
Chemical communications (Cambridge, England) (2018) 54, 24 2982-2985
a=10.716(3)Å b=18.530(4)Å c=13.213(3)Å
α=90° β=91.445(6)° γ=90°
C24H32N2O6
C24H32N2O6
Chemical communications (Cambridge, England) (2018) 54, 24 2982-2985
a=13.677(9)Å b=17.670(12)Å c=10.710(7)Å
α=90° β=106.085(14)° γ=90°
C28H18F4IrN5O2
C28H18F4IrN5O2
Journal of Materials Chemistry C (2015) 3, 7405-7420
a=16.765(2)Å b=15.096(8)Å c=20.6420(10)Å
α=90.00° β=90.00° γ=90.00°
C28H18F4IrN5O4,CH2Cl2
C28H18F4IrN5O4,CH2Cl2
Journal of Materials Chemistry C (2015) 3, 7405-7420
a=12.069(3)Å b=12.029(3)Å c=19.562(5)Å
α=90° β=92.189(4)° γ=90°
C23H15NO
C23H15NO
Journal of Materials Chemistry C (2015) 3, 10225-10231
a=9.805(15)Å b=13.501(18)Å c=13.18(2)Å
α=90° β=106.35(3)° γ=90°
C23H15NS
C23H15NS
Journal of Materials Chemistry C (2015) 3, 10225-10231
a=9.853(14)Å b=14.006(19)Å c=12.99(2)Å
α=90° β=107.08(2)° γ=90°
C25H18O2
C25H18O2
Chem.Commun. (2014) 50, 4616
a=12.0032(12)Å b=11.3220(11)Å c=13.1801(13)Å
α=90.00° β=102.273(2)° γ=90.00°
C25H20O2
C25H20O2
Chem.Commun. (2014) 50, 4616
a=25.153(9)Å b=7.204(3)Å c=19.717(7)Å
α=90.00° β=90.00° γ=90.00°
4-Phenyl-3,6-Di(2-pyridyl)pyridazine
C20H14N4
CrystEngComm (2009) 11, 8 1505
a=6.164(6)Å b=14.713(1)Å c=17.365(1)Å
α=90.00° β=95.380(1)° γ=90.00°
1,3,5-Benzene-tri-2,6-2-pyridyl pyridazine
C48H30N12,C4H10O
CrystEngComm (2009) 11, 8 1505
a=12.676(1)Å b=13.597(1)Å c=13.826(1)Å
α=73.300(2)° β=76.270(2)° γ=78.950(2)°
C34H22N8
C34H22N8
CrystEngComm (2009) 11, 8 1505
a=36.000(1)Å b=36.000(1)Å c=6.213(5)Å
α=90.00° β=90.00° γ=120.00°
CDPA-DMAP
C22H15N2O2,C7H11N2
CrystEngComm (2011) 13, 22 6706
a=7.6459(15)Å b=27.929(6)Å c=11.311(2)Å
α=90.00° β=91.84(3)° γ=90.00°
CDPA-Propylamine
C26H26.5N3.5O2
CrystEngComm (2011) 13, 22 6706
a=20.497(8)Å b=6.687(3)Å c=20.628(8)Å
α=90.00° β=118.114(7)° γ=90.00°
C18H16N10O,2(C2H6O),H2O
C18H16N10O,2(C2H6O),H2O
CrystEngComm (2013) 15, 20 4117
a=8.710(4)Å b=10.353(5)Å c=14.973(7)Å
α=107.204(10)° β=92.640(11)° γ=94.681(11)°
C18H16N10O,H2O
C18H16N10O,H2O
CrystEngComm (2013) 15, 20 4117
a=15.882(4)Å b=7.619(2)Å c=17.176(4)Å
α=90.00° β=115.635(5)° γ=90.00°
C18H16N10O
C18H16N10O
CrystEngComm (2013) 15, 20 4117
a=8.9692(18)Å b=10.621(2)Å c=14.453(3)Å
α=83.86(3)° β=85.29(3)° γ=77.44(3)°
C18H18N10O2
C18H18N10O2
CrystEngComm (2013) 15, 20 4117
a=12.342(3)Å b=13.853(3)Å c=14.853(3)Å
α=90.00° β=101.91(3)° γ=90.00°
C18H16N10O,C2H6OS,O
C18H16N10O,C2H6OS,O
CrystEngComm (2013) 15, 20 4117
a=8.3660(10)Å b=9.9820(10)Å c=14.679(2)Å
α=91.4650(10)° β=97.580(3)° γ=105.924(3)°
C66H32F21O7Yb
C66H32F21O7Yb
RSC Adv. (2016)
a=14.204(3)Å b=15.184(3)Å c=17.459(4)Å
α=113.560(10)° β=108.085(15)° γ=94.308(12)°
C17H13NO2
C17H13NO2
Physical chemistry chemical physics : PCCP (2015) 17, 28 18768-18779
a=8.804(7)Å b=7.685(5)Å c=21.631(15)Å
α=90.00° β=100.287(12)° γ=90.00°
C90H54F12N12O6P2Ru
C90H54F12N12O6P2Ru
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=18.443(4)Å b=18.443(4)Å c=12.820(3)Å
α=90.00° β=90.00° γ=120.00°
C74H60Cu2N8O7P4
C74H60Cu2N8O7P4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 33 8320-8327
a=14.570(4)Å b=19.092(5)Å c=28.652(7)Å
α=90° β=113.424(12)° γ=90°
C77H64Cl2Cu2N6O6P4
C77H64Cl2Cu2N6O6P4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 33 8320-8327
a=14.673(3)Å b=19.071(4)Å c=26.536(6)Å
α=90.00° β=96.795(4)° γ=90.00°
C75H62Cl2Cu2N8O6P4
C75H62Cl2Cu2N8O6P4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 33 8320-8327
a=14.570(4)Å b=19.092(5)Å c=26.482(8)Å
α=90.00° β=96.897(7)° γ=90.00°
C18H12N6
C18H12N6
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=11.0611(6)Å b=18.2383(10)Å c=7.3490(4)Å
α=90.00° β=90.00° γ=90.00°
C19H13N5
C19H13N5
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=9.4836(19)Å b=11.136(2)Å c=14.432(3)Å
α=90.00° β=90.87(3)° γ=90.00°
C41H34F12N10OP2Ru
C41H34F12N10OP2Ru
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=10.9856(10)Å b=20.2230(18)Å c=20.3436(18)Å
α=90.00° β=104.637(2)° γ=90.00°
C39H29N9Ru,C3H6O,2(F6P)
C39H29N9Ru,C3H6O,2(F6P)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=11.5464(10)Å b=19.7510(18)Å c=19.7135(17)Å
α=90.00° β=101.996(2)° γ=90.00°
C24H14N4
C24H14N4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=21.426(2)Å b=10.0132(10)Å c=7.9162(8)Å
α=90.00° β=90.00° γ=90.00°
C26H18N4
C26H18N4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=10.4660(10)Å b=12.1740(10)Å c=15.882(2)Å
α=93.6740(10)° β=91.256(4)° γ=101.7500(10)°
C44H30N8Ru,2(F6P),3(CH2Cl2)
C44H30N8Ru,2(F6P),3(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8206-8212
a=9.006(1)Å b=43.982(3)Å c=13.043(1)Å
α=90.00° β=101.319(2)° γ=90.00°
Methyl-6-ferrocenylnaphthalene-2-carboxylate
C22H18FeO2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 35 8228-8239
a=14.7851(17)Å b=6.1301(7)Å c=18.161(2)Å
α=90.00° β=92.273(3)° γ=90.00°
Methyl-3-ferrocenylnaphthalene-2-carboxylate
C22H18FeO2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 35 8228-8239
a=13.9797(15)Å b=8.7249(9)Å c=13.9843(15)Å
α=90.00° β=103.111(2)° γ=90.00°
Pentaacqua-tris-(3,5-dinitro-4- methylbenzoato)praseodymium(iii) complex
[Pr(C8H5N2O6)3(H2O)2].3(H2O)
Chemical Communications (2005)
a=9.483(3)Å b=12.593(3)Å c=15.517(4)Å
α=76.89(9)° β=78.10(9)° γ=81.33(9)°
Bisacqua-mono-(4,4'-bipyridyl)-tris-(3,5-dinitro-4- methylbenzoato) Praseodymium(iii) complex
[Pr(C8H5N2O6)3(H2O)2].(C10H8N2)
Chemical Communications (2005)
a=9.774(4)Å b=12.721(6)Å c=16.355(7)Å
α=72.01(9)° β=82.90(9)° γ=83.15(9)°
Tetraacqua-hemi-(1,2-bis(4-pyridyl)ethane)-tris-3,5-dinitro-4- methyl benzoato Praseodymium(iii) complex
[Pr(C8H5N2O6)3(H2O)2].0.5(C12H12N2).2(H2O)
Chemical Communications (2005)
a=9.517(2)Å b=12.747(2)Å c=16.366(3)Å
α=72.21(2)° β=78.98(3)° γ=79.84(2)°
C22H16N2O2,C4H9N
C22H16N2O2,C4H9N
Chem. Commun. (2009) 7500-7502
a=9.461(1)Å b=25.424(2)Å c=11.161(1)Å
α=90.00° β=125.704(5)° γ=90.00°
C22H16N2O2
C22H16N2O2
Chem. Commun. (2009) 7500-7502
a=13.568(1)Å b=9.459(1)Å c=13.642(1)Å
α=90.00° β=104.167(2)° γ=90.00°
C22H15N2O2,C4H10NO
C22H15N2O2,C4H10NO
Chem. Commun. (2009) 7500-7502
a=11.231(1)Å b=16.368(1)Å c=26.031(2)Å
α=99.435(1)° β=102.219(1)° γ=99.471(2)°
2(C22H16N2O2),C5H5N
2(C22H16N2O2),C5H5N
Chem. Commun. (2009) 7500-7502
a=7.877(1)Å b=9.424(1)Å c=26.835(3)Å
α=90.00° β=93.023(3)° γ=90.00°
2(C22H16N2O2),2(C5H11N),3(C2H3N)
2(C22H16N2O2),2(C5H11N),3(C2H3N)
Chem. Commun. (2009) 7500-7502
a=32.166(2)Å b=9.8996(7)Å c=16.4069(11)Å
α=90.00° β=90.00° γ=90.00°
C15H8AgF3N2O4S
C15H8AgF3N2O4S
CrystEngComm (2013) 15, 33 6602
a=5.1665(10)Å b=18.453(4)Å c=18.155(3)Å
α=90.00° β=90.00° γ=90.00°
C15H8AgF3N2O4S
C15H8AgF3N2O4S
CrystEngComm (2013) 15, 33 6602
a=11.093(4)Å b=12.530(4)Å c=12.330(4)Å
α=90.00° β=93.515(6)° γ=90.00°
C59H34Ag3F9N8O14S3
C59H34Ag3F9N8O14S3
CrystEngComm (2013) 15, 33 6602
a=14.141(3)Å b=15.663(3)Å c=16.402(3)Å
α=90.00° β=108.459(6)° γ=90.00°
C69 H54 N10 O6, 3(H2 O)
C69H60N10O9
Dalton transactions (Cambridge, England : 2003) (2015) 44, 35 15591-15601
a=15.68(2)Å b=16.44(2)Å c=17.69(2)Å
α=91.408(12)° β=115.658(13)° γ=117.999(12)°
C69 H56 Cu N10 O7, 2(Cl O4), 2(C3 H7 N O), 4(H2 O)
C75H78Cl2CuN12O21
Dalton transactions (Cambridge, England : 2003) (2015) 44, 35 15591-15601
a=15.244(8)Å b=15.370(9)Å c=17.480(9)Å
α=82.582(8)° β=80.483(19)° γ=88.567(19)°
C51H40GdN9O8
C51H40GdN9O8
Dalton transactions (Cambridge, England : 2003) (2014) 43, 28 10940-10946
a=30.229(8)Å b=14.919(3)Å c=10.217(3)Å
α=90.00° β=102.947(3)° γ=90.00°
C17H13N3O2
C17H13N3O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 28 10940-10946
a=10.737(6)Å b=8.327(5)Å c=16.382(9)Å
α=90.00° β=94.588(10)° γ=90.00°
3,5-Dihydroxybenzoic acid dipropyl oxalate
C8H14O4,6(C7H6O4),7(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=9.365(2)Å b=30.010(6)Å c=20.085(4)Å
α=90.00° β=100.22(3)° γ=90.00°
3,5-Dihydroxybenzoic acid dimethyloxalate
2(C7H6O4),0.5(C4H6O4),2(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=7.254(2)Å b=9.334(2)Å c=14.517(3)Å
α=99.12(3)° β=93.63(3)° γ=110.63(3)°
3,5-Dihydroxybenzoic acid ethyl acetate solvate
3(C7H6O4),C4H8O2,3(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=10.289(2)Å b=9.201(2)Å c=30.055(6)Å
α=90.00° β=97.54(3)° γ=90.00°
3,5-Dihydroxybenzoic acid acetone solvate
6(C7H6O4),2(C3H6O),5(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=30.096(6)Å b=9.118(2)Å c=20.170(4)Å
α=90.00° β=109.92(3)° γ=90.00°
3,5-Dihydroxybenzoic acid 1-propanol solvate
3(C7H6O4),C3H8O,3(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=22.701(5)Å b=9.293(2)Å c=26.502(5)Å
α=90.00° β=105.19(3)° γ=90.00°
3,5-Dihydroxybenzoic acid 2-butanol solvate
2(C7H6O4),0.5(C4H8O2),2(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=27.894(7)Å b=9.263(2)Å c=24.047(6)Å
α=90.00° β=144.111(14)° γ=90.00°
1,2-Bis(4-pyridyl)ethane-2,6-dihydroxybenzoic acid
C12H14N2,2(C7H5O4)
Crystal Growth & Design (2015) 15, 8 3832
a=8.325(1)Å b=6.947(1)Å c=19.916(2)Å
α=90.00° β=97.84(8)° γ=90.00°
1,2-Bis(4-pyridyl)ethene-2,5-dihydroxybenzoic acid complex
(C12H12N2),2(C7H5O4)
Crystal Growth & Design (2015) 15, 8 3832
a=6.827(1)Å b=8.734(2)Å c=9.852(2)Å
α=77.06(3)° β=72.84(3)° γ=87.22(3)°
1,2-Bis(4-pyridyl)ethane-2,5-dihydroxybenzoic acid complex
C12H13N2,C7H5O4
Crystal Growth & Design (2015) 15, 8 3832
a=8.015(10)Å b=18.131(2)Å c=11.088(10)Å
α=90.00° β=90.50(10)° γ=90.00°
1,2-bis(4-pyridyl)ethane-2,3-dihydroxybenzoic acid complex
C12H13N2,C7H5O4
Crystal Growth & Design (2015) 15, 8 3832
a=8.265(2)Å b=9.398(2)Å c=10.574(3)Å
α=91.08(2)° β=91.07(2)° γ=98.67(2)°
1,2-Bis(4-pyridyl)ethene-2,6-dihydroxybenzoic acid complex
C12H12N2,2(C7H5O4)
Crystal Growth & Design (2015) 15, 8 3832
a=8.298(1)Å b=6.879(1)Å c=20.191(2)Å
α=90.00° β=98.30(8)° γ=90.00°
1,2-bis(4-pyridyl)ethene-2,4-dihydroxybenzoic acid complex
C12H10N2,C7H6O4
Crystal Growth & Design (2015) 15, 8 3832
a=3.811(1)Å b=10.342(3)Å c=10.844(3)Å
α=65.84(3)° β=85.83(3)° γ=89.45(3)°
1,2-Bis(4-pyridyl)ethene - 2,3-dihydroxybenzoic acid complex
(C12H12N2),2(C7H5O4)
Crystal Growth & Design (2015) 15, 8 3832
a=9.588(1)Å b=10.431(1)Å c=13.187(1)Å
α=90.00° β=123.94(5)° γ=90.00°
1,2-bis(4-pyridyl)ethane-3,4-dihydroxybenzoic acid complex
C12H12N2,C7H6O4
Crystal Growth & Design (2015) 15, 8 3832
a=9.174(2)Å b=12.815(3)Å c=14.399(3)Å
α=86.24(2)° β=86.33(1)° γ=77.38(2)°
(E)-1,2-di(pyridine-4-yl)diazene Iodine
C10H8N4,2(I2)
Crystal Growth & Design (2015) 15, 5 2389
a=6.589(3)Å b=7.514(3)Å c=9.181(4)Å
α=66.435(5)° β=82.250(6)° γ=79.808(6)°
(E)-1,2-di(pyridin-4-yl)diazene 1,2,4,5-benzenetetracarboxylic acid
C10H10N4,C10H4O8
Crystal Growth & Design (2015) 15, 5 2389
a=9.749(4)Å b=7.643(3)Å c=13.372(5)Å
α=90.00° β=109.464(5)° γ=90.00°
(E)-1,2-di(pyridine-4-yl)diazene 3,5-dinitrobenzamide
C10H8N4,2(C7H5N3O5)
Crystal Growth & Design (2015) 15, 5 2389
a=6.6042(11)Å b=8.0953(14)Å c=13.127(2)Å
α=106.487(3)° β=98.862(3)° γ=95.887(3)°
(E)-1,2-di(pyridine-4-yl)diazene 1,2,4,5-tetrafluoro-3,6-dibromdobenzene
C10H8N4,C6Br2F4
Crystal Growth & Design (2015) 15, 5 2389
a=15.236(6)Å b=5.0195(16)Å c=11.782(4)Å
α=90.00° β=112.679(5)° γ=90.00°
(E)-1,2-di(pyridine-4-yl)diazene Resorcinol
C10H8N4,C6H6O2
Crystal Growth & Design (2015) 15, 5 2389
a=8.059(4)Å b=9.776(4)Å c=10.885(4)Å
α=94.425(5)° β=106.298(5)° γ=113.321(6)°
(E)-1,2-di(pyridine-4-yl)diazene 1,2,4,5-tetrafluoro-3,6-diiodobenzene
C10H8N4,C6F4I2
Crystal Growth & Design (2015) 15, 5 2389
a=6.414(4)Å b=8.358(5)Å c=9.202(6)Å
α=82.982(9)° β=70.979(9)° γ=78.678(9)°
(E)-1,2-di(pyridine-4-yl)diazene 1,4-diiodotetrafluorobenzene
C10H8N4,C6H4I2
Crystal Growth & Design (2015) 15, 5 2389
a=10.05(2)Å b=9.71(2)Å c=9.00(2)Å
α=90.00° β=100.22(4)° γ=90.00°
(E)-1,2-di(pyridine-4-yl)diazene 1,6-diiodoperfluorohexane
C12H10N2,C6F12I2
Crystal Growth & Design (2015) 15, 5 2389
a=5.3105(10)Å b=8.8507(17)Å c=11.980(2)Å
α=92.264(3)° β=94.826(3)° γ=90.157(3)°
C12H10N2,2(C7H6O3)
C12H10N2,2(C7H6O3)
Crystal Growth & Design (2015) 15, 5 2389
a=8.7577(6)Å b=6.8083(5)Å c=19.6624(16)Å
α=90.00° β=105.338(7)° γ=90.00°
C12H8N2,C6H6BIO2
C12H8N2,C6H6BIO2
Crystal Growth & Design (2014) 14, 8 4143
a=19.700(8)Å b=7.072(3)Å c=25.731(10)Å
α=90.00° β=107.705(6)° γ=90.00°
C12H8N2,C6H5BBrO2,H2O
C12H8N2,C6H5BBrO2,H2O
Crystal Growth & Design (2014) 14, 8 4143
a=7.095(4)Å b=10.015(6)Å c=13.341(8)Å
α=90.954(13)° β=95.037(11)° γ=93.988(14)°
C13H9N,C6H6BClO2
C13H9N,C6H6BClO2
Crystal Growth & Design (2014) 14, 8 4143
a=11.092(6)Å b=7.246(4)Å c=21.061(13)Å
α=90.00° β=99.211(11)° γ=90.00°
2(C12H8N2),C6H6BIO2,H2O
2(C12H8N2),C6H6BIO2,H2O
Crystal Growth & Design (2014) 14, 8 4143
a=8.996(5)Å b=12.502(6)Å c=14.051(7)Å
α=109.397(4)° β=94.074(6)° γ=110.188(6)°
4-Iodophenylboronic acid-4,4'-bipyridyl-hydrate complex
C10H8N2,C6H6BIO2,H2O
Crystal Growth & Design (2014) 14, 8 4143
a=13.251(5)Å b=6.858(3)Å c=18.594(8)Å
α=90.00° β=103.50(7)° γ=90.00°
C13H9N,C6H6BIO2
C13H9N,C6H6BIO2
Crystal Growth & Design (2014) 14, 8 4143
a=7.384(8)Å b=11.183(9)Å c=12.070(2)Å
α=110.2970(10)° β=103.060(2)° γ=94.720(2)°
2(C12H8N2),C6H6BBrO2,H2O
2(C12H8N2),C6H6BBrO2,H2O
Crystal Growth & Design (2014) 14, 8 4143
a=8.982(6)Å b=12.482(8)Å c=13.945(8)Å
α=109.230(5)° β=95.719(5)° γ=110.223(7)°
4-Chlorophenylboronic acid-4,7-phenanthroline complex
C12H8N2,C6H6BClO2
Crystal Growth & Design (2014) 14, 8 4143
a=7.506(2)Å b=9.118(2)Å c=11.635(4)Å
α=79.24(3)° β=88.39(2)° γ=84.33(2)°
4-Bromophenylboronic acid-4,7-phenanthroline complex
C12H8N2,C6H6BBrO2
Crystal Growth & Design (2014) 14, 8 4143
a=7.621(4)Å b=9.054(5)Å c=11.668(6)Å
α=80.58(2)° β=88.21(2)° γ=84.07(2)°
C13H9N,C6H6BBrO2
C13H9N,C6H6BBrO2
Crystal Growth & Design (2014) 14, 8 4143
a=7.218(4)Å b=11.132(6)Å c=11.861(7)Å
α=109.402(10)° β=104.453(4)° γ=94.515(5)°
4-Iodophenylboronic acid-trans-1,2-bis(4-pyridyl)ethene complex
3(C12H10N2),2(C6H6BIO2)
Crystal Growth & Design (2014) 14, 8 4143
a=10.129(4)Å b=10.900(4)Å c=12.521(4)Å
α=69.960(8)° β=66.850(8)° γ=70.210(7)°
4-Bromophenylboronic acid-4,4'-bipyridyl-hydrate complex
C10H8N2,C6H6BBrO2,H2O
Crystal Growth & Design (2014) 14, 8 4143
a=12.805(3)Å b=6.8340(10)Å c=18.647(4)Å
α=90.00° β=102.74(3)° γ=90.00°
4-Iodophenylboronic acid-4,7-phenanthroline complex
C12H8N2,2(C6H6BIO2)
Crystal Growth & Design (2014) 14, 8 4143
a=7.202(2)Å b=34.347(8)Å c=21.339(5)Å
α=90.00° β=105.660(8)° γ=90.00°
4-Chlorophenylboronic acid-trans-1, 2-bis(4-pyridyl)ethene-hydrate complex
(C12H10N2),(C6H6BClO2),(H2O)
Crystal Growth & Design (2014) 14, 8 4143
a=12.259(5)Å b=12.938(2)Å c=13.211(3)Å
α=96.91(1)° β=116.79(2)° γ=99.83(2)°
4-Bromophenylboronic acid-trans-1,2-bis(4-pyridyl)ethene-hydrate complex
(C12H10N2),(C6H6BBrO2),(H2O)
Crystal Growth & Design (2014) 14, 8 4143
a=12.301Å b=12.969Å c=13.309Å
α=96.25(1)° β=116.94(1)° γ=100.13(1)°
3,5-Dihydroxybenzoic acid N,N-dimethyformamide solvate
3(C7H6O4),C3H6NO,3(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=29.955(6)Å b=9.256(2)Å c=22.870(5)Å
α=90.00° β=122.45(3)° γ=90.00°
3,5-Dihydroxybenzoic acid diethyl malonate
C7H12O4,6(C7H6O4),7(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=9.328(1)Å b=15.646(1)Å c=19.666(1)Å
α=78.955(6)° β=86.028(6)° γ=73.359(5)°
3,5-Dihydroxybenzoic acid diethyl succinate
C8H14O4,6(C7H6O4),6(H2O)
Crystal Growth & Design (2010) 10, 9 4184
a=9.374(1)Å b=11.126(1)Å c=15.366(2)Å
α=109.467(7)° β=90.876(7)° γ=113.693(4)°
C10H8N4,2(C7H4N2O6)
C10H8N4,2(C7H4N2O6)
Crystal Growth & Design (2015) 15, 5 2389
a=4.6421(12)Å b=9.923(3)Å c=14.773(4)Å
α=106.135(4)° β=93.894(4)° γ=91.467(4)°
C29H24N2O3S
C29H24N2O3S
The Journal of organic chemistry (2017) 82, 19 10537-10548
a=10.969(6)Å b=14.515(6)Å c=15.540(7)Å
α=90° β=109.929(8)° γ=90°
[Co(II)(bis-bipyridine)(tetrakis(3,5-dinitro benzene-1-carboxylic acid))methanol]
4(C7H3N2O6):2(C10H8N2):CH30:2Co:C3H6O
Inorganic Chemistry (2004) 43, 450-457
a=22.774(2)Å b=11.375(1)Å c=22.533(2)Å
α=90.00° β=104.15(1)° γ=90.00°